|
Asanbaeva A.A., Brimkulov N.N.
On the issue of the prevalence of osteopenic syndrome in combination with COPD among residents of different altitudes of Kyrgyzstan
|
№4 / 2024
|
|
Trushina E.Yu., Kostina E.M., Tipikin V.A., Orlova E.A.
Triple therapy in the treatment of patients with a combination of chronic obstructive pulmonary disease and bronchial asthma
|
№1 / 2024
|
|
E.Yu. Trushina, E.M. Kostina, V.A. Tipikin, E.A. Orlova
Modern ideas about the combination of bronchial asthma and chronic obstructive pulmonary disease
|
№14 / 2023
|
|
Yu.G. Belotserkovskaya, A.G. Romanovskikh, I.P. Smirnov
Problems of managing patients with COPD in the post-pandemic waves of COVID-19
|
№9/10 / 2023
|
|
L.V. Vasilyeva, E.V. Gosteva, E.Yu. Suslova, L.R. Elzhurkaeva, M.A. Zolotareva
Pathogenetic mechanisms of the association of MMP-9 and TIMP-1 biomarkers with the severity of chronic obstructive pulmonary disease
|
№9/10 / 2023
|
|
N.V. Bagisheva, A.V. Mordyk, I.A. Viktorova, M.V. Moiseeva, S.V. Sitnikova, A.R. Aroyan
New-onset pulmonary tuberculosis in a patient with chronic obstructive pulmonary disease and coronary artery disease, angina pectoris: treatment options
|
№5 / 2022
|
|
E.Yu. Trushina, E.M. Kostina
Markers of eosinophilic and neutrophilic inflammation of respiratory tract in patients with non-allergic bronchial asthma and chronic obstructive pulmonary disease
|
№5 / 2021
|
|
N.V. Bagisheva (1), A.V. Mordyk (1), I.A. Viktorova (1), K.I. Nesterova (1), V.V. Goltyapin (2), A.R. Aroyan (1), S.A. Rudenko (3), N.V. Shirinskaya (4)
Factor analysis of medical risk factors for the development of an unfavorable outcome of tuberculosis treatment in comorbid patients
|
№5 / 2021
|
|
L.V. Vasilyeva (1), E.N. Bezzubtseva (1), E.F. Evstratova (1), E.V. Gosteva (1), I.B. Zubkova (2)
Clinical significance of genetic and inflammatory markers of bone metabolism in patients with chronic obstructive pulmonary disease and osteoporosis
|
№5 / 2021
|
|
A.I. Sinopalnikov
Bronchodilator therapy for COPD: a 20-year road
|
№5 / 2021
|
|
N.A. Karoli, A.P. Rebrov
Beta-blockers in patients with chronic obstructive pulmonary disease: for whom, when, how?
|
№5 / 2020
|
|
I.V. Leshchenko (1, 2), V.E. Evdokimov (1)
The place of nebulizer therapy in clinical practice
|
№5 / 2020
|
Русский
